OptiNose Inc (OPTN)
0.9087
+0.08
(+10.28%)
USD |
NASDAQ |
May 01, 16:00
0.9087
0.00 (0.00%)
After-Hours: 20:00
OptiNose Total Liabilities (Quarterly): 194.34M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 194.34M |
| September 30, 2023 | 179.02M |
| June 30, 2023 | 175.73M |
| March 31, 2023 | 188.71M |
| December 31, 2022 | 200.85M |
| September 30, 2022 | 178.69M |
| June 30, 2022 | 183.62M |
| March 31, 2022 | 178.67M |
| December 31, 2021 | 187.84M |
| September 30, 2021 | 183.39M |
| June 30, 2021 | 176.59M |
| March 31, 2021 | 174.61M |
| December 31, 2020 | 182.02M |
| September 30, 2020 | 153.34M |
| Date | Value |
|---|---|
| June 30, 2020 | 140.44M |
| March 31, 2020 | 139.04M |
| December 31, 2019 | 111.07M |
| September 30, 2019 | 104.86M |
| June 30, 2019 | 98.10M |
| March 31, 2019 | 100.64M |
| December 31, 2018 | 98.38M |
| September 30, 2018 | 94.89M |
| June 30, 2018 | 95.62M |
| March 31, 2018 | 94.45M |
| December 31, 2017 | 86.64M |
| September 30, 2017 | 68.57M |
| June 30, 2017 | 6.225M |
| December 31, 2016 | 45.39M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
98.10M
Minimum
Jun 2019
200.85M
Maximum
Dec 2022
164.78M
Average
178.67M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 235.21M |
| Viking Therapeutics Inc | 33.63M |
| Zevra Therapeutics Inc | 110.46M |
| Spero Therapeutics Inc | 75.50M |
| Karuna Therapeutics Inc (DELISTED) | 81.97M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 107.73M |
| Shareholders Equity (Quarterly) | -86.61M |
| Debt to Equity Ratio | -1.504 |
| Current Ratio | 0.5967 |
| Net Debt Paydown Yield | -0.29% |